Literature DB >> 3168375

Tc-99m hexamethylpropylene-amine oxine (HM-PAO) uptake in a bone metastasis.

H Hoshi1, S Jinnouchi, M Sameshima, O Uwada, K Watanabe.   

Abstract

Uptake of Tc-99m Hexamethylpropylene-amine Oxine (HM-PAO) was seen in bone metastases from carcinoma of the lung. The uptake was prominent when compared to Tc-99m MDP, I-123 IMP, and Ga-67 citrate. Brain imaging with Tc-99m HM-PAO and N-isopropyl-p-[I-123] iodoamphetamine (IMP) is now frequently performed. Uptake of these agents has been reported in brain tumors and melanomas. In this report, uptake of Tc-99m HM-PAO in a metastatic lesion in bone is discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3168375     DOI: 10.1097/00003072-198808000-00011

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  3 in total

1.  Comparison of technetium 99m-phytate and technetium 99m-sulphur colloid in primary bone tumours.

Authors:  P N Rao; S N Murthy; S N Muddukrishna; S Devaru; E R Radhakrishnan; M K Bhargava
Journal:  Eur J Nucl Med       Date:  1990

2.  Evaluation of primary lung carcinoma using technetium 99m-hexamethylpropylene amine oxime: preliminary clinical experience.

Authors:  M Oshima; K Itoh; S Okae; M Tadokoro; Y Kodama; S Sakuma
Journal:  Eur J Nucl Med       Date:  1990

3.  Accumulation of 99mTc-HM-PAO in photon deficient areas in bone scan of bone metastasis from hepatocellular carcinoma.

Authors:  N Otsuka; M Fukunaga; K Morita; S Ono; K Nagai; T Tomomitsu; S Yanagimoto; H Mimura; S Yamamoto; Y Hirano
Journal:  Ann Nucl Med       Date:  1992-11       Impact factor: 2.668

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.